Ayman Semaan | Head of Market Access & Pricing
Biologix

Ayman Semaan Market Access & Pricing Lead, Biologix Pharma Member, HTAi, Rare Diseases Working Group Ayman Semaan is the Market Access & Pricing Lead at Biologix Pharma, where he oversees strategy and execution across the Middle East and North Africa (MENA) region. With close to 20 years of leadership experience across Market Access, Pricing, Sales, and Marketing, he has a distinguished record in driving equitable and sustainable access to transformative therapies in Rare Diseases, Hematology/Oncology, Neurology, Immunology, and Cardio-Metabolic Disorders. A recognized expert in health economics and access policy, Ayman has led the development of innovative pricing and reimbursement models, including managed entry agreements and the first national performance-based risk-sharing arrangement in the MENA region. His expertise spans value-based healthcare, HTA/HEOR integration, and pricing frameworks that balance innovation, affordability, and long-term sustainability. He holds a master’s degree in health sciences from the Lebanese University and Joseph Fourier (Grenoble Alpes) University and is an alumnus of the General Management Program at École Supérieure des Affaires (ESA). Ayman served as Director of Communications for the ISPOR Lebanon Chapter (2023-25), in addition to being an active member of HTAi Rare Diseases and Public Health Working Groups.